• Ingénieur hospitalier
  • CHU
  • 05 49 45 41 79

Publications HAL

  • Alexandre Maisterrena, Emmanuel Matas, Helene Mirfendereski, Anais Balbous, Sandrine Marchand, et al.. The State of the Dopaminergic and Glutamatergic Systems in the Valproic Acid Mouse Model of Autism Spectrum Disorder. Biomolecules, 2022, 12 (11), pp.1691. ⟨10.3390/biom12111691⟩. ⟨hal-03906794⟩
  • Emmanuel Matas, Alexandre Maisterrena, Mathieu Thabault, Eric Balado, Maureen Francheteau, et al.. Major motor and gait deficits with sexual dimorphism in a Shank3 mutant mouse model. Molecular Autism, 2021, 12 (1), pp.2. ⟨10.1186/s13229-020-00412-8⟩. ⟨hal-03150112⟩
  • Obélia Haida, Tareq Al Sagheer, Anais Balbous, Maureen Francheteau, Emmanuel Matas, et al.. Sex-dependent behavioral deficits and neuropathology in a maternal immune activation model of autism. Translational Psychiatry, 2019, 9 (1), ⟨10.1038/s41398-019-0457-y⟩. ⟨hal-02347455⟩
  • Audrey Voisin, Christelle Monville, Alexandra Plancheron, Anais Balbous, Afsaneh Gaillard, et al.. hRPE cells derived from induced pluripotent stem cells are more sensitive to oxidative stress than ARPE-19 cells. Experimental Eye Research, 2018, 177, pp.76-86. ⟨10.1016/j.exer.2018.07.017⟩. ⟨hal-02498060⟩
  • Gaelle Tachon, Ulrich Cortes, Pierre-Olivier Guichet, Pierre Rivet, Anais Balbous, et al.. Cell Cycle Changes after Glioblastoma Stem Cell Irradiation: The Major Role of RAD51. International Journal of Molecular Sciences, 2018, 19 (10), pp.3018. ⟨10.3390/ijms19103018⟩. ⟨hal-02538718⟩
  • Tareq Al Sagheer, Obélia Haida, Anais Balbous, Maureen Francheteau, Emmanuel Matas, et al.. Motor Impairments Correlate with Social Deficits and Restricted Neuronal Loss in an Environmental Model of Autism. International Journal of Neuropsychopharmacology, 2018, 21 (9), pp.871-882. ⟨10.1093/ijnp/pyy043⟩. ⟨hal-02347494⟩
  • Konstantin Masliantsev, Baptiste Pinel, Anais Balbous, Pierre-Olivier Guichet, Gaelle Tachon, et al.. Impact of STAT3 phosphorylation in glioblastoma stem cells radiosensitization and patient outcome. Oncotarget, 2018, 9 (3), pp.3968-3979. ⟨10.18632/oncotarget.23374⟩. ⟨hal-02538688⟩
  • Audelaure Junca, Claire Villalva, Gaelle Tachon, Pierre Rivet, Ulrich Cortes, et al.. Crizotinib targets in glioblastoma stem cells. Cancer Medicine, 2017, 6 (11), pp.2625-2634. ⟨10.1002/cam4.1167⟩. ⟨hal-02538685⟩
  • Anais Balbous, Ulrich Cortes, Karline Guilloteau, Pierre Rivet, Baptiste Pinel, et al.. A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells. BMC Cancer, 2016, 16 (1), ⟨10.1186/s12885-016-2647-9⟩. ⟨hal-02538679⟩
  • Anais Balbous, Brigitte Renoux, Ulrich Cortes, Serge Milin, Karline Guilloteau, et al.. Selective Release of a Cyclopamine Glucuronide Prodrug toward Stem-like Cancer Cell Inhibition in Glioblastoma. Molecular Cancer Therapeutics, 2014, 13 (9), pp.2159-2169. ⟨10.1158/1535-7163.MCT-13-1038⟩. ⟨hal-01313891⟩
  • Mohamed Jaber, Obélia Haida, Tareq Al Sagheer, Anais Balbous, Maureen Francheteau, et al.. Sex dependent behavioral deficits and neuropathology in environmental mouse models of autism. Neuroscience 2019, Oct 2019, San Diego, CA, United States. ⟨hal-02555657⟩
  • Emmanuel Matas, Tareq Al Sagheer, Obélia Haida, Anais Balbous, Maureen Francheteau, et al.. Environmental models of autism spectrum disorder display fine motor deficits and sex specific restricted neuronal loss. Neuroscience 2018, Nov 2018, San Diego, CA, United States. ⟨hal-02555634⟩
  • Tareq Al Sagheer, Obélia Haida, Anais Balbous, Maureen Francheteau, Pierre Olivier Fernagut, et al.. Motor impairments correlate with social deficits in two environmental animal models of autism. FENS, Jul 2018, Berlin, Germany. ⟨hal-02538815⟩
  • Emmanuel Matas, Anais Balbous, Obélia Haida, Tareq Al Sagheer, Maureen Francheteau, et al.. Prenatal exposure to valproic acid activates mammalian target of rapamycin (mTOR) signaling pathway in the mouse cerebellum and motor cortex. FENS, Jul 2018, Berlin, Germany. ⟨hal-02538775⟩
  • Obélia Haida, Tareq Al Sagheer, Anais Balbous, Maureen Francheteau, Pierre Olivier Fernagut, et al.. Purkinje cell loss in Autism Poly I:C prenatal exposure causes social and motor deficits and induces neuronal loss in a sex-dependent manner. FENS, Jul 2018, Berlin, Germany. ⟨hal-02538805⟩
  • Tareq Al Sagheer, Obélia Haida, Anais Balbous, Emmanuel Matas, Maureen Francheteau, et al.. Motor determinants of Autism Spectrum Disorders. NeuroFrance International meeting, May 2018, Bordeaux, France. ⟨hal-02556930⟩
  • Tareq Al Sagheer, Obélia Haida, Anais Balbous, Emmanuel Matas, Maureen Francheteau, et al.. Motor Determinants of Autism Spectrum Disorders. SFR FED 4226 Neuroimagerie Fonctionnelle Journée scientifique, Jun 2017, Poitiers, France. ⟨hal-02555709⟩
  • Audrey Voisin, Christelle Monville, Alexandra Plancheron, Anais Balbous, Afsaneh Gaillard, et al.. ARPE-19 : the best cell to model retinal disease in vitro ?. Journée Scientifique de la Société Fédérative de la Recherche FED 4246 Neuroimagerie Fonctionnelle, Jun 2017, Poitiers, France. ⟨hal-02498140⟩
  • Audrey Voisin, Christelle Monville, Alexandra Plancheron, Anais Balbous, Afsaneh Gaillard, et al.. ARPE-19 : the best cell to model retinal disease in vitro ?. NeuroFrance 2017, May 2017, Bordeaux, France. ⟨hal-02498146⟩
  • Audrey Voisin, Christelle Monville, Alexandra Plancheron, Anais Balbous, Afsaneh Gaillard, et al.. ARPE-19 : the best cell to model retinal disease in vitro ?. ARVO, May 2017, Baltimore, United States. ⟨hal-02498149⟩
  • Tareq Al Sagheer, Obélia Haida, Anais Balbous, Emmanuel Matas, Maureen Francheteau, et al.. Purkinje cell loss in Autism Spectrum Disorders mouse models.. Neurofrance, May 2017, Bordeaux, France. ⟨hal-02538820⟩
  • Tareq Al Sagheer, Obélia Haida, Anais Balbous, Emmanuel Matas, Maureen Francheteau, et al.. Motor Determinants of Autism Spectrum Disorders. Bordeaux Neurocampus day, Apr 2017, Bordeaux, France. ⟨hal-02557053⟩
  • Konstantin Masliantsev, Baptiste Pinel, Anais Balbous, Pierre-Olivier Guichet, Serge Milin, et al.. Radiosensitization of Glioblastoma Stem Cells by inhibition of STAT3. Canceropole Grand Sud-Ouest, Nov 2016, Montpellier, France. ⟨hal-02538770⟩
  • Tareq Al Sagheer, Obélia Haida, Anais Balbous, Pierre Olivier Fernagut, Maureen Francheteau, et al.. Motor behavior in mouse models of autism spectrum disorders and underlying cellular and molecular mechanisms. 10th FENS Forum of Neuroscience, Jul 2016, Copenhagen, Denmark. ⟨hal-02555697⟩
  • Audrey Voisin, Alexandra Plancheron, Marie-Laure Bonnet, Anais Balbous, Christelle Monville, et al.. Development of a cellular model of dry AMD. 2ème Journées Thématiques de la Société des Neurosciences et la Société Fédérative de la Recherche FED 4246 Neuroimagerie Fonctionnelle, May 2016, Tours, France. ⟨hal-02498154⟩
  • Tareq Al Sagheer, Obélia Haida, Anais Balbous, Maureen Francheteau, Pierre Olivier Fernagut, et al.. Motor behavior alterations in animal models of Autism Spectrum Disorders.. 2e Journées Thématiques de la Société des Neurosciences, May 2016, Tours, France. ⟨hal-02556920⟩
  • Obélia Haida, Tareq Al Sagheer, Anais Balbous, Sébastien Brot, Maureen Francheteau, et al.. Molecular and cellular alterations underlying motor disorders in autism spectrum disorders mouse models. Séminaire thématique bio-santé ED 524, Mar 2016, Pouligny-Notre-Dame, France. ⟨hal-02556995⟩
  • Anais Balbous, Brigitte Renoux, Ulrich Cortes, Serge Milin, Karline Guilloteau, et al.. Etude de l’effet du premier vecteur glucuronylé de la cyclopamine sur les cellules initiatrices de glioblastomes. 6ème journée de la Recherche Tours-Poitiers, Nov 2013, Poitiers, France. ⟨hal-02538758⟩
  • Anais Balbous, Thibaut Legigan, Brigitte Renoux, Ulrich Cortes, Pierre Rivet, et al.. Etude de l’effet du premier vecteur glucuronylé de la cyclopamine sur les cellules initiatrices de glioblastomes. 6ème journée du Cancéropole Grand-Ouest Tours-Poitiers, Angers, Jun 2012, Angers, France. ⟨hal-02538745⟩
  • Anais Balbous, Thibaut Legigan, Brigitte Renoux, Ulrich Cortes, Pierre Rivet, et al.. Etude de l’effet du premier vecteur glucuronylé de la cyclopamine sur les cellules initiatrices de glioblastomes. 6ème colloque du Cancéropole PACA- Glioblastomes, Feb 2012, Marseille, France. ⟨hal-02538740⟩

A propos

 

Anais (195x250)

EQUIPE de rattachement : Equipe 3

NOM Prénom : BALBOUS-GAUTIER Anaïs

Statut : Ingénieur hospitalier

Adresse :

Laboratoire de Neurosciences Expérimentales et Cliniques (LNEC), Unité INSERM1084 Pôle Biologie Santé – B36 1, rue Georges Bonnet TSA 51106 86073 Poitiers –  Cedex 9
Tél : 05 49 45 41 79

e-mail : anais.balbous@univ-poitiers.fr ou anais.balbous-gautier@chu-poitiers.fr

Publications : Lien vers la liste des publications ici

  • Suivez nous sur les réseaux sociaux